The alterations in carbohydrate metabolism during pregnancy are discussed and possible mechanisms for these changes are put forward. It is stressed that the raised levels of plasma glucose, the enhanced response to insulin and the decreased tissue sensitivity to insulin are all features of normal pregnancy. It may be difficult to distinguish this from very early forms of diabetes mellitus during pregnancy, the detection of which is briefly considered.
Introduction
While doctors agree that there is a range of 'normal' physiological values many seem to believe that there are relatively narrow limits to this range and any conspicuous deviation from it can only be caused by disease. Yet even among healthy people there must be allowances for age, sex and 'fitness'; it is improbable that the physiological responses of a 20-year-old male athlete are indistinguishable from those of a 60-year-old housewife. This comparison would no doubt be judged unfair by most doctors because the differences in physiological status would be self-evident. But pregnancy induces major physiological adaptations in the mother which are less obvious but may, in some instances, be so marked as to mimic disease. The changes occurring in carbohydrate metabolism are a particularly good example because allowances are rarely made for any pregnancy effect when 'diabetes' is suspected. It is the purpose of the author to discuss in this paper the influence of normal, uncomplicated pregnancy upon carbohydrate metabolism and help to define the circumstances in which true diabetes mellitus might be suspected.
Pregnancy influence upon carbohydrate metabolism
All the data to be described have been obtained using a standard 50 g oral glucose tolerance test (OGTT) unless some other procedure is specified. The reasons for the preference of this test over the intravenous glucose tolerance test have been discussed elsewhere (Lind, 1975) .
Fasting plasma values
Glucose. It is generally accepted that the fasting plasma glucose value is lower during pregnancy (Bleicher, O'Sullivan and Freinkel, 1964; Tyson and Merimee, 1970) but the exact timing of this change has been generally attributed to the first trimester. Lind, Billewicz and Brown (1973) (Table 1) . 
Increased proinsulin production
In the insulin immunoassay used in this unit (Lind et al., 1972) (Phelps et al., 1975; Kiihl, 1977) .
Insulin metabolism
The raised amount of circulating insulin could be due to a decreased clearance rate from the circulation rather than an increase in production. To pregnancy has no effect on the kinetics of insulin (Lind et al., 1977) . This is in keeping with the report of Bellmann and Hartmann (1975) using human data and natural rather than radioiodinated insulin.
Glucose tolerance fiactor
It has been suggested that chromium, incorporated into a specific organic complex in the body, named glucose tolerance factor (GTF), is a necessary intermediary between the insulin molecule and its cell membrane receptors (Mertz, 1967 (Mertz, 1967) ) and 10 acted as control subjects. All of these patients were subsequently delivered of healthy infants after uncomplicated pregnancies.
Each patient fasted overnight for at least 12 hr and then had a standard 50 g OGTT; this first test was undertaken at about 30 weeks' gestation. The 10 patients being tested were then asked to take 10 g/day of brewer's yeast (Saccharomyces uvarum [-carlsbergensis]) in fruit juice; this contains about 11 g of GTF (Toepfer et al., 1973) . The control subjects drank the same volume of fruit juice daily After 2 weeks the OGTT was repeated.
A more elaborate test programme was undertaken in 11 maturity onset diabetic patients controlled by diet alone, and in 17 non-pregnant women. These women were tested at regular intervals during the menstrual cycle because of the known variation in the OGTT response curve during the follicular and luteal phases. Insulin response to glucose. The increase in circulating insulin levels has been discussed previously and summarized in Tables I and 2 . By term, the fasting level has increased, more circulating insulin is found 2 hr after a glucose load, and glucose infusions promote an enhanced insulin response.
Reduced peripheral uptake oj glucose. In the reported study of insulin half-life (Lind et al., 1977) it was found that an intravenous dose of insulin of 0-02 u./kg body-weight given to fasted pregnant women at about 36 weeks' gestation reduced the fasting plasma glucose by about one mmol/l. A similar dose given to the same women 10-12 weeks after delivery reduced the fasting level by about 1.8 mmol/l. Glucagon response. Four women in the above study had their glucagon determined by a specific immunoassay which cross-reacted to less than 0.10 with human gut glucagon (Kiihl and Holst, 1976) . Blood samples were obtained at one-min intervals for 3 min before the insulin injection; the concentrations of plasma glucose, insulin and glucagon were determined and the means of the 3 measurements in each patient taken as the normal 'fasting levels'. After injection of the insulin one min was allowed for mixing then further blood samples were obtained at one-min intervals for 30 min; full details of the methods have been published elsewhere (Lind et al., 1977 
Preliminary conclusionis
These data were all derived from perfectly healthy women having uncomplicated pregnancies, and the same women acted as their own non-pregnant control group. Thus 'carbohydrate intolerance' manifested as higher plasma glucose values, an enhanced insulin response, and a decreased tissue sensitivity to insulin are features of normal pregnancy. Why these changes occur is difficult to define; the altered hormonal milieu of pregnancy is usually held to be responsible and this is probably so. Certainly the changes rapidly revert to normal after delivery (Lind and Harris, 1976) . However it would be an oversimplification to hold any one hormone, such as human placental lactogen, responsible; the whole complex of altered maternal adaptations, including changes in protein and fat metabolism, probably combine to influence changes in carbohydrate homoeostasis. The clinical problem is to define the upper limit of the normal range of pregnancy responses from the early forms of diabetes mellitus.
The diagnosis of disordered carbohydrate metabolism
The practice of detecting diabetes mellitus from the presence of glycosuria is based upon the fact that a significant increase in blood glucose will produce a filtered load of glucose in the proximal renal tubule which the kidney is incapable of absorbing. This is not true of pregnancy; about 50/% of all healthy, pregnant women have glycosuria at some stage while their blood glucose levels remain well within normal limits (Davison and Hytten, 1975 ). This is not, therefore, a sufficiently selective screening procedure for antenatal clinics; if the obstetrician wishes to detect women with abnormally elevated blood glucose concentrations, then it is blood glucose which ought to be determined.
Glycosylated haemoglobin
Space does not permit of a detailed account of the development of the glysocylated haemoglobins, currently denoted as Hb A1(a+b+c), as possible monitors of diabetic status and the reader is referred to Rahbar (1968) ; Trivelli, Ranney and Lai (1971) ; Bunn et al. (1976); Fitzgibbons, Koler and Jones (1976) and Koenig et al. (1976) among others. In essence it appears that the glycosylated haemoglobins form some 6-8% of the total haemoglobin in a normal healthy population but about 12-14% in reasonably well controlled insulin-dependent diabetics. As these haemoglobins are slow to form and relatively irreversible once formed they may offer a method of checking long-term blood glucose control in treated diabetics. The longer the blood glucose concentration remains elevated the greater will be the proportion of Hb Al(a,b+c). Thus diabetics attending a clinic will have their immediate status determined by blood or urinary glucose profiles, but a knowledge of the proportion of glycosylated haemoglobin may allow the clinician to assess what degree of control the patient has achieved over the previous 4-8 weeks.
The possible roles for these haemoglobins can be considered by the obstetrician: (i) such determinations may offer a further method of controlling pregnant diabetic patients and (ii) they may offer a screening method for unsuspected diabetes during pregnancy.
